HNC364
- Generic Name
- HNC364
A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Guangzhou Henovcom Bioscience Co. Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT05523570
- Locations
- 🇺🇸
Frontage Clinical Services, Inc., Secaucus, New Jersey, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath